基础医学与临床 ›› 2017, Vol. 37 ›› Issue (4): 454-462.

• 子宫内膜癌专题 • 上一篇    下一篇

子宫内膜癌淋巴结转移的危险因素及预后分析

曾靖1,李艳2,金滢2,2,单莹1,王永学1,尹婕3,韩甜甜1,宋晓1,潘凌亚3   

  1. 1. 北京协和医院
    2. 北京协和医院妇产科
    3. 中国医学科学院 北京协和医学院 北京协和医院
  • 收稿日期:2017-02-23 修回日期:2017-02-27 出版日期:2017-04-05 发布日期:2017-03-24
  • 通讯作者: 李艳 E-mail:laoliyan@163.com

High-Risk Factors and Prognostic analysis of Pelvic Nodal Metastasis in Patients with Endometrial Carcinoma

  • Received:2017-02-23 Revised:2017-02-27 Online:2017-04-05 Published:2017-03-24

摘要: 目的:探讨子宫内膜癌腹膜后淋巴结转移的高危因素及淋巴结转移对于预后的影响。方法:回顾性分析2005年1月至2010年12月期间在北京协和医院妇产科进行诊治的289例行腹膜后淋巴结切除的子宫内膜癌患者的临床病理资料,对影响子宫内膜癌腹膜后淋巴结转移的高危因素和影响子宫内膜癌患者预后的因素进行统计分析。结果:(1)289例患者中位发病年龄55岁,I期224例(77.5%),II期13例(4.5%),III期45例(15.6%),IV期7例(2.4%)。289例行盆腔淋巴结切除,30例(10.4%)有盆腔淋巴结转移;96例行腹主动脉旁淋巴结切除,11例(11.5%)有腹主动脉旁淋巴结转移。复发21例(7.3%),死亡11例(3.8%),中位随访时间37个月,中位无瘤生存时间34个月。(2)单因素分析显示术前CA125≥35u/L、非子宫内膜样癌、组织学分级为G3、深肌层浸润、肿瘤≥2cm、宫颈间质受累、腹腔冲洗液细胞学阳性及阴道或宫旁受累是淋巴结转移率的高危因素(P<0.05)。多因素分析显示术前CA125值≥35U/ml、低分化、肌层浸润深度≥1/2是淋巴结转移的独立危险因素(P<0.05)。(3)Kaplan-Meier单因素分析显示,腹腔冲洗液细胞学阳性、阴道或宫旁受累、附件受累及淋巴结转移缩短无瘤生存时间(P<0.05);非子宫内膜样癌、低分化、肌层浸润深度≥1/2、腹腔冲洗液细胞学阳性、附件受累及淋巴结转移缩短总生存时间(P<0.05)。COX回归多因素分析显示,腹膜后淋巴结转移是5年无瘤生存率的独立预后因素(未转移者92.1% vs 转移者65.3%,P=0.002,95%CI 0.078-0.552);虽不是5年总生存率的独立预后因素,但无淋巴结转移者的5年总生存率有高于淋巴结转移者的趋势(未转移者96.1% vs 转移者70.0%,P=0.086,95%CI 0.039-1.238)。结论:本研究发现,(1)肿瘤分化程度和肌层浸润深度对淋巴结转移有预测意义,能够指导内膜癌患者是否进行淋巴结切除术,为个体化治疗奠定理论基础。(2)淋巴结转移患者仍然有较无淋巴结转移者预后更差的趋势,因此对于淋巴结转移的患者需要进行辅助治疗,减少复发风险。

关键词: 子宫内膜癌, 淋巴结, 影响因素, 预后

Abstract: Objective: To investigate the high-risk factors of retroperitoneal lymph nodes metastasis (LNM) and the effect of lymph nodes metastasis on prognosis in patients with endometrial carcinoma (EM). Methods: Retrospective research were carried out from January 2005 to December 2010 to identify 289 endometrial cancer patients treated with retroperitoneal lymphadenectomy at Peking Union Medical College Hospital. The high-risk factors of retroperitoneal LNM and prognostic factors of this disease were studied. Results: (1) The median age of at diagnosis was 55 years. Patients of stage I, II, III and IV were 224 (77.5%), 13 (4.5%), 45 (15.6%) and 7 (2.4%), respectively. Two hundred and eighty-nine patients received pelvic lymphadenectomy, of that 30 (10.4%) patients were found the pelvic LNM. Ninety-six patients received periaortic lymphadenectomy, of that 11 (11.5%) patients were found the periaortic LNM. Twenty-one (7.3%) patients developed recurrent disease and 11 (3.8 %) were dead. The median follow-up was 37 months and the median disease-free survival (DFS) was 34 months. (2) In univariate analysis, the incidence of LNM significantly increased in patients with CA125 ≥ 35u/L preoperatively , non-endometrioid adenocarcinoma, low grade, deep myometrium invasion, diameter of tumor ≥ 2cm, cervical stroma involvement, positive peritoneal cytology and vagina or parametrial involvement (P < 0.05). In multivariate analysis, CA125 ≥ 35u/L preoperatively, low grade, deep myometrium invasion was the independent high-risk factors of LNM (P < 0.05). (3) The Kaplan-Meier analysis showed a significant difference between positive peritoneal cytology, vagina or parametrial involvement, appendix involvement, LNM and DFS (P < 0.05). We also found a significant difference on the impact of non-endometrioid adenocarcinoma, low grade, deep myometrium invasion, positive peritoneal cytology, appendix involvement and LNM on overall survival (OS) (P < 0.05). Cox regression analysis revealed retroperitoneal LNM is the independent prognostic factor of 5-year DFS (patients without LNM 92.1% vs patients with LNM 65.3%, P=0.002, 95%CI 0.078-0.552). We also found the trend that the 5-year OS was higher in patients without LNM than them with LNM, even though there was no significant difference (patients without LNM 96.1% vs patients with LNM 70.0%, P=0.086, 95%CI 0.039-1.238). Conclusion: Our study found that (1) there was the predictive value of low grade and deep myometrium invasion for EC patients with LNM. This finding may give the clinician a guild of lymphadenectomy and lay the foundation for individualized treatment; (2) there was the trend that patients with LNM have poorer prognosis than them without LNM. Therefore, patients with LNM should receive adjuvant therapy to reduce the risk of recurrence.

Key words: Endometrial carcinoma, lymph nodes, High-risk factors, prognosis

中图分类号: